Literature DB >> 11687552

Hsp25 and -90 immunoreactivity in the normal rat eye.

D O Dean1, M Tytell.   

Abstract

PURPOSE: The distributions of heat shock protein (Hsp)25 and -90 in various regions of the rat eye are described to provide a basis for understanding their roles in normal, damaged, and diseased ocular tissues. This work complements the earlier examination of Hsp70 and Hsc70 (the constitutive form).
METHODS: Eyes of adult male Sprague-Dawley rats were fixed in methacarn and embedded in paraffin. Sagittal sections (10 microm) through the optic nerve were stained with hematoxylin and eosin, or incubated with anti-Hsp90, anti-Hsp25, or control IgG. Bound antibody was visualized using an avidin-biotin-horseradish peroxidase detection system.
RESULTS: Hsp90 immunoreactivity was abundant in the retina, whereas only low levels of Hsp25 were detected there. In the optic nerve, the relative difference in immunoreactivity for the two Hsps was reversed, with Hsp25 being considerably greater than Hsp90. Both Hsps were detected at low levels in the retinal pigment epithelium (RPE), except for that portion within 250 microm of the optic disc, where Hsp25 and -90 immunoreactivities were increased. Similar to the optic nerve, the corneal epithelium showed greater staining for Hsp25 than for Hsp90, and basal cells contained the highest levels of immunoreactivity for both Hsps. In the ciliary body and iris, Hsp25 and -90 were abundant and similarly distributed in the epithelial and stromal layers.
CONCLUSIONS: Each of the ocular tissues had distinctive patterns of Hsp25 and -90 immunostaining. These results suggest that the various structures of the eye have unique requirements for the particular chaperoning and supportive functions of these two Hsp families.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687552

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Hsp90 as a Potential Therapeutic Target in Retinal Disease.

Authors:  Mònica Aguilà; Michael E Cheetham
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 2.  HspB1 (Hsp 27) expression and neuroprotection in the retina.

Authors:  Amanda M O'Reilly; R William Currie; David B Clarke
Journal:  Mol Neurobiol       Date:  2010-06-02       Impact factor: 5.590

3.  Assessment of heat shock protein (HSP60, HSP72, HSP90, and HSC70) expression in cultured limbal stem cells following air lifting.

Authors:  Marzeih Ebrahimi; Parvaneh Mohammadi; Arezoo Daryadel; Hossein Baharvand
Journal:  Mol Vis       Date:  2010-08-18       Impact factor: 2.367

4.  Genome-wide analysis and expression profiling of the small heat shock proteins in zebrafish.

Authors:  Kimberly S Elicker; Lara D Hutson
Journal:  Gene       Date:  2007-08-19       Impact factor: 3.688

5.  Detection of heat shock protein 70 in choroidal neovascular membranes secondary to age related macular degeneration.

Authors:  Andreas P W Jöres; Dörthe Carstesen; Gabriele Thumann; Peter Walter; Andreas W A Weinberger
Journal:  BMC Res Notes       Date:  2011-04-08

6.  Exploiting the diversity of the heat-shock protein family for primary and secondary tauopathy therapeutics.

Authors:  Jose F Abisambra; Umesh K Jinwal; Jeffrey R Jones; Laura J Blair; John Koren; Chad A Dickey
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

7.  Essential role of thioredoxin 2 in mitigating oxidative stress in retinal epithelial cells.

Authors:  Eriko Sugano; Namie Murayama; Maki Takahashi; Kitako Tabata; Makoto Tamai; Hiroshi Tomita
Journal:  J Ophthalmol       Date:  2013-11-10       Impact factor: 1.909

Review 8.  The cell stress machinery and retinal degeneration.

Authors:  Dimitra Athanasiou; Monica Aguilà; Dalila Bevilacqua; Sergey S Novoselov; David A Parfitt; Michael E Cheetham
Journal:  FEBS Lett       Date:  2013-05-15       Impact factor: 4.124

Review 9.  Heat Shock Proteins Regulatory Role in Neurodevelopment.

Authors:  David J Miller; Patrice E Fort
Journal:  Front Neurosci       Date:  2018-11-12       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.